These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4948481)

  • 21. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
    Hogerzeil LM
    Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
    [No Abstract]   [Full Text] [Related]  

  • 22. Intra-neural ceroid-like pigment following the treatment of lepromatous leprosy with clofazimine (B663; Lamprene).
    McDougall AC; Jones RL
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):116-20. PubMed ID: 6260900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'B 663' POSSIBLE ANTI-INFLAMMATORY ACTION IN LEPROMATOUS LEPROSY.
    BROWNE SG
    Lepr Rev; 1965 Jan; 36():9-11. PubMed ID: 14241920
    [No Abstract]   [Full Text] [Related]  

  • 24. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 25. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
    Devadason C
    Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical evaluation of drugs for leprosy.
    Browne SG
    Trans R Soc Trop Med Hyg; 1967; 61(4):601-7. PubMed ID: 4861314
    [No Abstract]   [Full Text] [Related]  

  • 28. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.
    Pattyn SR
    Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832
    [No Abstract]   [Full Text] [Related]  

  • 29. Leprosy. A preliminary review of the experimental evaluation of drugs for the treatment of leprosy.
    Rees RJ
    Trans R Soc Trop Med Hyg; 1967; 61(4):581-95. PubMed ID: 4167891
    [No Abstract]   [Full Text] [Related]  

  • 30. The lack of effect of methimazole therapy in lepromatous leprosy. Reassessment by examination of bacterial morphology.
    Levy L; Murray LP; Fasal P
    Int J Lepr Other Mycobact Dis; 1967; 35(2):149-53. PubMed ID: 4165669
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute abdomen in a patient treated with lamprene.
    Jagadeesan K; Visweswaran MK; Iyer KH
    Int Surg; 1975 Apr; 60(4):208-9. PubMed ID: 1091577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clofazimine in leprosy.
    Browne SG
    Br Med J; 1972 Feb; 1(5798):506-7. PubMed ID: 4550304
    [No Abstract]   [Full Text] [Related]  

  • 34. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
    Renders A
    Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of neuritis in leprosy.
    Pfaltzgraff RE
    Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065
    [No Abstract]   [Full Text] [Related]  

  • 36. Clofazimine (B663, Geigy) in leprosy reactions.
    Smith RB
    Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapeutic trials in leprosy. 6. Pilot study of the riminophenazine derivative B.663 in low dosage (100 mgm. twice weekly) in the treatment of lepromatous leprosy.
    Waters MF
    Int J Lepr Other Mycobact Dis; 1968; 36(4):391-9. PubMed ID: 4898403
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation of laboratory and clinical data during treatment of leprosy.
    Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
    Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
    [No Abstract]   [Full Text] [Related]  

  • 40. Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966-1978.
    Browne SG; Harman DJ; Waudby H; McDougall AC
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):167-76. PubMed ID: 7196886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.